Study of a novel small molecule, LT3001, in a thromboembolic stroke model in non-human primates

LT3001 is a novel small molecule designed to have thrombolytic and free radical scavenging activities. Its potential safety and efficacy in treating acute ischemic stroke was evaluated using a thromboembolic stroke model in adult Cynomolgus macaque.
Source: Journal of Stroke and Cerebrovascular Diseases - Category: Neurology Authors: Source Type: research